tradingkey.logo
tradingkey.logo

Rockwell Medical Inc

RMTI
0.849USD
-0.001-0.09%
終値 12/19, 16:00ET15分遅れの株価
33.46M時価総額
損失額直近12ヶ月PER

Rockwell Medical Inc

0.849
-0.001-0.09%

詳細情報 Rockwell Medical Inc 企業名

Rockwell Medical, Inc. is a healthcare company. The Company develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. The Company operates in the hemodialysis market, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceuticals, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process. Its hemodialysis concentrates products are used to sustain a patient's life by removing toxins and balancing electrolytes in a dialysis patient’s bloodstream. The Company is the supplier of liquid and dry, acid and bicarbonate concentrates for dialysis patients in the United States. The Company manufactures hemodialysis concentrates at its facilities in Michigan, South Carolina, and Texas, and the Company manufactures its dry acid concentrate mixers at its facility in Iowa.

Rockwell Medical Incの企業情報

企業コードRMTI
会社名Rockwell Medical Inc
上場日Jan 27, 1998
最高経営責任者「CEO」Strobeck (Mark)
従業員数244
証券種類Ordinary Share
決算期末Jan 27
本社所在地30142 Wixom Road
都市WIXOM
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号48393
電話番号18004493353
ウェブサイトhttps://www.rockwellmed.com/
企業コードRMTI
上場日Jan 27, 1998
最高経営責任者「CEO」Strobeck (Mark)

Rockwell Medical Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%
Mr. Jesse Neri
Mr. Jesse Neri
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
105.95K
-0.83%
Mr. Robert S. Radie
Mr. Robert S. Radie
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Heather R. Hunter
Ms. Heather R. Hunter
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Allen R. Nissenson, M.D.
Dr. Allen R. Nissenson, M.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Mark Strobeck, Ph.D.
Dr. Mark Strobeck, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
283.69K
-2.38%
Mr. Mark H. Ravich
Mr. Mark H. Ravich
Independent Director
Independent Director
151.10K
+49.45%
Ms. Megan Timmins, J.D.
Ms. Megan Timmins, J.D.
Executive Vice President, Chief Legal Officer, Secretary
Executive Vice President, Chief Legal Officer, Secretary
142.68K
+215.79%
Mr. John G. Cooper, CPA
Mr. John G. Cooper, CPA
Independent Director
Independent Director
140.37K
-3.49%
Mr. Timothy Chole
Mr. Timothy Chole
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
128.12K
-2.19%
Dr. Joan Lau, Ph.D.
Dr. Joan Lau, Ph.D.
Independent Director
Independent Director
113.11K
+79.23%

収益内訳

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%
地域別USD
会社名
収益
比率
United States
14.19M
0.00%
Rest of World
1.88M
0.00%
事業別
地域別
事業別USD
会社名
収益
比率
Concentrate Products
16.07M
0.00%
Drug Products
0.00
0.00%

株主

更新時刻: Tue, Nov 18
更新時刻: Tue, Nov 18
株主統計
種類
株主統計
株主統計
比率
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
他の
84.57%
株主統計
株主統計
比率
Irrevocable Larson Family Investment Trust
9.03%
The Vanguard Group, Inc.
3.44%
Renaissance Technologies LLC
1.43%
Geode Capital Management, L.L.C.
0.82%
Strobeck (Mark)
0.72%
他の
84.57%
種類
株主統計
比率
Corporation
9.03%
Investment Advisor
4.95%
Individual Investor
4.20%
Hedge Fund
2.01%
Investment Advisor/Hedge Fund
1.47%
Research Firm
0.09%
Venture Capital
0.04%
他の
78.21%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
98
6.21M
18.04%
-1.88M
2025Q2
119
12.15M
35.56%
-1.45M
2025Q1
124
11.25M
32.97%
-1.96M
2024Q4
123
12.47M
38.59%
-1.21M
2024Q3
113
13.08M
41.13%
+2.79M
2024Q2
102
9.50M
31.23%
+460.06K
2024Q1
118
5.89M
19.90%
-1.12M
2023Q4
118
5.97M
23.48%
-688.25K
2023Q3
122
6.04M
24.13%
+2.56M
2023Q2
133
3.92M
24.44%
+947.21K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Irrevocable Larson Family Investment Trust
3.56M
10.33%
+87.50K
+2.52%
Apr 11, 2025
The Vanguard Group, Inc.
1.21M
3.5%
--
--
Jun 30, 2025
Renaissance Technologies LLC
541.75K
1.57%
+88.75K
+19.59%
Jun 30, 2025
Geode Capital Management, L.L.C.
320.67K
0.93%
-3.87K
-1.19%
Jun 30, 2025
Strobeck (Mark)
290.62K
0.84%
-6.93K
-2.33%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
217.66K
0.63%
+1.98K
+0.92%
Jun 30, 2025
Ravich (Mark H)
151.10K
0.44%
+50.00K
+49.45%
May 20, 2025
Radie (Robert Samuel)
143.52K
0.42%
+50.00K
+53.46%
May 20, 2025
Timmins (Megan Carden)
142.68K
0.41%
+97.50K
+215.79%
May 20, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
iShares Micro-Cap ETF
比率0.01%
Dimensional US Core Equity 1 ETF
比率0%
DFA Dimensional US Sustainability Core 1 ETF
比率0%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
日付
種類
比率
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1
May 12, 2022
Merger
11→1

よくある質問

Rockwell Medical Incの上位5名の株主は誰ですか?

Rockwell Medical Incの上位5名の株主は以下のとおりです。
Irrevocable Larson Family Investment Trustは3.56M株を保有しており、これは全体の10.33%に相当します。
The Vanguard Group, Inc.は1.21M株を保有しており、これは全体の3.50%に相当します。
Renaissance Technologies LLCは541.75K株を保有しており、これは全体の1.57%に相当します。
Geode Capital Management, L.L.C.は320.67K株を保有しており、これは全体の0.93%に相当します。
Strobeck (Mark)は290.62K株を保有しており、これは全体の0.84%に相当します。

Rockwell Medical Incの株主タイプ上位3種は何ですか?

Rockwell Medical Incの株主タイプ上位3種は、
Irrevocable Larson Family Investment Trust
The Vanguard Group, Inc.
Renaissance Technologies LLC

Rockwell Medical Inc(RMTI)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Rockwell Medical Incの株式を保有している機関は98社あり、保有株式の総市場価値は約6.21Mで、全体の18.04%を占めています。2025Q2と比較して、機関の持ち株は-17.52%増加しています。

Rockwell Medical Incの最大の収益源は何ですか?

FY2025Q2において、Concentrate Products部門がRockwell Medical Incにとって最大の収益を生み出しており、その金額は16.07Mで、全収益の--%を占めています。
KeyAI